Heart rate variability improvement in children using transcatheter atrial septal defect closure

İsa Özyılmaz1, Yakup Ergül, Hasan Tahsin Tola

  • 1Department of Pediatric Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center and Research Hospital; İstanbul-Turkey. isaozy@hotmail.com.

Insights

Transcatheter closure of atrial septal defects (ASD) positively impacts heart rate variability (HRV) in children. Autonomic function, measured by HRV, recovers to normal levels within six months post-procedure.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Autonomic Nervous System Research

Background:

  • Atrial septal defect (ASD) can affect autonomic nervous system function.
  • Heart rate variability (HRV) is a key indicator of autonomic behavior.
  • Transcatheter closure is a common treatment for ASD in pediatric patients.

Purpose of the Study:

  • To evaluate the effect of transcatheter ASD closure on heart rate variability (HRV) in children.
  • To assess changes in time-domain and frequency-domain HRV parameters before and after the procedure.
  • To determine the long-term recovery of HRV following transcatheter ASD closure.

Main Methods:

  • A prospective study involving 47 pediatric patients undergoing transcatheter ASD closure and 30 healthy controls.
  • Holter electrocardiography (ECG) was performed pre-procedure, one day post-procedure, and six months post-procedure.
  • Analysis of time-domain (SDNN, rMSSD, SDANN) and frequency-domain (VLF, LF, HF, VHF, LF/HF) HRV parameters using Student's t-test.

Main Results:

  • Pre-procedure, pediatric ASD patients exhibited lower HRV values compared to healthy controls in both time and frequency domains.
  • Following transcatheter closure, HRV values in the patient group gradually approached those of the control group.
  • By six months post-procedure, HRV parameters in the patient group showed no statistically significant difference compared to the control group.

Conclusions:

  • Transcatheter closure of secundum ASDs has a beneficial effect on pediatric HRV.
  • Improved HRV post-procedure suggests a potential reduction in mortality and morbidity.
  • Pediatric HRV demonstrates recovery approximately six months after transcatheter ASD closure.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
456
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
549
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
567
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.2K